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Abstract
Spontaneous mutations of the Sharpin (SHANK-associated RH domain-interacting protein, other aliases: Rbckl1, Sipl1) gene in
mice result in systemic inflammation that is characterized by chronic proliferative dermatitis and dysregulated secretion of T
helper1 (Th1) and Th2 cytokines. The cellular and molecular mechanisms underlying this inflammatory phenotype remain
elusive. Dendritic cells may contribute to the initiation and progression of the phenotype of SHARPIN-deficient mice
because of their pivotal role in innate and adaptive immunity. Here we show by flow cytometry that SHARPIN- deficiency
did not alter the distribution of different DC subtypes in the spleen. In response to TOLL-like receptor (TLR) agonists LPS and
poly I:C, cultured bone marrow-derived dendritic cells (BMDC) from WT and mutant mice exhibited similar increases in
expression of co-stimulatory molecules CD40, CD80, and CD86. However, stimulated SHARPIN-deficient BMDC had reduced
transcription and secretion of pro-inflammatory mediators IL6, IL12P70, GMCSF, and nitric oxide. Mutant BMDC had
defective activation of NF-kB signaling, whereas the MAPK1/3 (ERK1/2) and MAPK11/12/13/14 (p38 MAP kinase isoforms)
and TBK1 signaling pathways were intact. A mixed lymphocyte reaction showed that mutant BMDC only induced a weak
Th1 immune response but stimulated increased Th2 cytokine production from allogeneic naı ¨ve CD4
+ T cells. In conclusion,
loss of Sharpin in mice significantly affects the immune function of DC and this may partially account for the systemic
inflammation and Th2-biased immune response.
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Introduction
SHARPIN was originally identified in post-synaptic densities of
excitatory synapses in the brain of rats [1], but this protein is
widely expressed in a variety of tissues [2]. Two allelic, autosomal
recessive mutations in the Sharpin gene occurred spontaneously in
two inbred strains of mice, C57B/KaLawRij-Sharpin
cpdm/Shar-
pin
cpdm and CBy.Ocb3/Dem-Sharpin
cpdm-Dem/Sharpin
cpdm-Dem, result-
ing in premature termination of mRNA synthesis and absence of a
functional protein product [2]. Despite different genetic back-
grounds, both mutations cause similar inflammatory disease with
severe chronic progressive dermatitis and defective development of
secondary lymphoid organs [2–4]. The dermatitis becomes
clinically apparent at about four weeks of age. There are
accumulations of eosinophils, neutrophils and macrophages in
the skin of Sharpin
cpdm/Sharpin
cpdm mutant mice (hereafter referred
to as cpdm mice) associated with increased expression of Th2
cytokines in the skin and in the supernatants of activated
splenocytes [5]. The mice have an impaired delayed type
hypersensitivity response and decreased secretion of IFNc [5],
indicating a defect in Th1 immune responses and a bias towards a
Th2 immune response. Systemic treatment of cpdm mice with
recombinant IL12 caused complete remission of the dermatitis [5].
Neutralization of IL5 by antibody treatment or crosses with IL5-
deficient mice reduced the number of circulating and cutaneous
eosinophils, but failed to reduce the onset and severity of the
dermatitis [6].
Recently, three independent groups identified SHARPIN as an
essential component of the linear ubiquitin chain assembly
complex (LUBAC) that regulates TNFa-induced canonical NF-
kB signaling [7–9]. SHARPIN-deficient mouse embryonic
fibroblast (MEF) were sensitized to TNFa-induced apoptosis and
cell death was implicated as a factor in the dermatitis of cpdm mice
[7–9].
Dendritic cells (DC) have a sentinel role in sensing pathogen or
danger signals and initiate and direct activation of the adaptive
immune response [10]. Activated and mature DC can carry
processed antigenic peptides, migrate to lymphoid organs, and
induce T-cell-mediated immune responses or tolerance. DC direct
the differentiation of CD4
+ T cells, and hence the type of immune
response, through the selective secretion of cytokines. We
hypothesized that defective cytokine secretion by DC contributed
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e31809to the Th2-biased inflammatory phenotype in SHARPIN-deficient
mice. The studies reported here found that lack of SHARPIN
protein in BMDC caused defective expression of pro-inflamma-
tory mediators and impaired NF-kB activation upon ligand
stimulation. The ability of cpdm BMDC to stimulate Th1 cytokine
production in allogeneic CD4
+ T cells was compromised. Taken
together, these results reveal that SHARPIN is a novel regulatory
molecule in DC biology and suggest that the dysregulated function
of SHARPIN-deficient DC plays a role in the cpdm phenotype.
Results
Characterization of Sharpin
Orthologs of SHARPIN protein are found in various species,
including human, mouse and rat. Motif prediction programming,
using COILS [11] and MotifScan [12], suggests that SHARPIN
contains a coiled-coil (CC) domain, a ubiquitin-like (UBL)
domain, and a zinc-finger Ran-binding protein 2 (ZFRBP)
domain. These functional motifs constitute similar domain
profiles that are present in the SHARPIN protein of all three
origins (Fig. 1A), suggesting that SHARPIN exerts highly
conserved functions across species. Spontaneous mutations in
the mouse Sharpin gene results in a complex inflammatory
phenotype characterized by severe dermatitis (Fig. 1B), systemic
inflammation and an enlarged spleen (Fig. 1C) caused by
extramedullary hematopoiesis [3]. The endogenous expression
of Sharpin mRNA in BMDC was determined by quantitative real
time-PCR (qRT-PCR) following culture in medium only or after
stimulation with LPS. Sharpin mRNA was present in BMDC
generated from WT mice (Fig. 1D) and its level was modestly
decreased by LPS stimulation. There was a significant reduction
of Sharpin mRNA (6–7-fold) in BMDC generated from cpdm mice.
Transfection of Flag-tagged Sharpin in fibroblasts (NIH3T3) and
macrophages (RAW264.7) indicated cytoplasmic localization of
the SHARPIN protein (Fig. 1E).
Phenotyping splenic DC and BMDC from WT and cpdm
mice
DC are heterogeneous and can be categorized into multiple
subtypes based on surface markers [13]. To determine if the
Sharpin mutation affects DC development in lymphoid tissues,
mouse spleens were examined for the distribution of conventional
DC (cDC; CD11c
+CD8a
+ and CD11c
+CD8a
2) [13] and
plasmacytoid DC (pDC; CD11c
2PDCA-1
+) [14]. The percentag-
es for splenic cDC and pDC were both reduced in cpdm mice when
compared with WT controls (Fig. 2A). However, when gated on
CD11c
+ cDC, the percentages of CD8a
+ and CD8a
2 cells were
not affected by SHARPIN deficiency (Fig. 2A). Since the spleen of
cpdm mice is markedly enlarged and contains three times as many
cells (Fig. 1C), the different percentages of splenic cDC and pDC
between WT and mutant mice reflect the increased number of
total spleen cells rather than a reduction in cDC and pDC
numbers. These data indicate that the Sharpin mutation does not
affect the distribution of the examined DC subsets in the spleen.
BMDC from in vitro cultures functionally resemble non-
lymphoid tissue DC and monocyte-derived inflammatory DC
[15,16]. The yields of BMDC from WT and cpdm mice were
similar. BMDC were CD11c
+ and MHC II
+ with low expression
of co-stimulatory molecules CD40, CD80, and CD86. The TLR3
ligand poly I:C and the TLR4 ligand LPS each activate
overlapping but different signaling pathways and were used to
induce DC maturation [17,18]. Incubation with the TLR agonists
for 24 hours resulted in increased expression of CD40, CD80, and
CD86 on BMDC; however, there was no difference in the
expression levels of these markers between WT and cpdm BMDC
(Fig. 2B). Thus, SHARPIN deficiency did not influence the
expression of co-stimulatory molecules by BMDC.
Production of proinflammatory mediators by cpdm
BMDC is impaired
Incubation with LPS or poly I:C resulted in secretion of IL6,
IL12P70, and GMCSF from both WT and cpdm BMDC; however,
BMDC from cpdm mice produced significantly less of all three
cytokines compared with WT BMDC (Fig. 3A–C, E–F). The
amount of nitric oxide generated by mutant BMDC was also
significantly reduced compared with WT cells (Fig. 3D), indicating
severely disrupted production of proinflammatory mediators from
Sharpin-deficient BMDC. In vivo complementation with a Sharpin
gene-containing BAC reversed the phenotype of the mutant mice
[2], and BMDC generated from these rescued mice secreted
significantly more IL12P70 than BMDC from cpdm mice (Fig. 3G),
supporting a necessary role of SHARPIN for the production of
IL12P70. In addition, the transcript levels of the inflammatory
cytokines Il6, Il12p40, Gmcsf, and Ifnb were examined, and these
were all significantly reduced in stimulated cpdm BMDC when
compared with WT controls (Fig. 4).
Impaired cytokine production by cpdm BMDC is
correlated with selective defects in NF-kB signaling
There are a number of possible explanations for the defective
cytokine secretion in stimulated cpdm BMDC, including 1) reduced
surface expression of the LPS receptor complex, 2) increased
production of anti-inflammatory mediators, 3) increased expres-
sion of negative regulators of TLR pathways, and 4) impaired
TLR-induced signaling activation.
We determined the surface expression of the LPS receptor
complex that comprises TLR4, the accessory proteins CD14 and
myeloid differentiation factor 2 (MD2/LY96) [19]. Flow cytomet-
ric analysis shows that the expression levels of CD14 and TLR4/
MD2 between WT and cpdm BMDC were similar (Fig. 5A). We
then quantified the secretion of the suppressive cytokines IL10 that
can inhibit IL12 secretion in an autocrine manner [20,21]. The
supernatants from LPS-stimulated cpdm BMDC contained signif-
icantly lower levels of IL10 than stimulated WT BMDC (Fig. 5B),
suggesting that IL10 was not responsible for decreased secretion of
IL12P70 by cpdm BMDC. Increased expression of a negative
regulator of TLR signaling such as A20 [22] may also suppress
cytokine secretion. However, the transcript level of A20 was lower
in LPS-activated cpdm BMDC than WT controls (Fig. 5C), thereby
ruling out overexpression of A20 as a factor in the reduced
cytokine production.
The transcription of TLR3/4-induced proinflammatory inter-
mediates is tightly regulated by cellular signaling pathways, in
particular NF-kB, TBK1/IRF3, and MAPK [23–27]. We next
determined if disrupted NF-kB, TBK1/IRF3, and/or MAPK
signaling may underlie the impaired cytokine production from
stimulated Sharpin-deficient BMDC. Stimulus-induced phosphor-
ylation of the IkB kinase (IKK1/2) is an essential step in NF-kB
signaling, allowing phosphorylation and proteasome-mediated
degradation of the NF-kB inhibitor IkBa to release the NF-kB
transcription factors into the nucleus. The amount of phosphor-
ylated IKK1/2 (p-IKK1/2) and IkBa (p-IkBa) following incuba-
tion with LPS or poly I:C was severely decreased in cpdm BMDC
as compared with WT controls (Fig. 6). The cpdm BMDC
exhibited similar levels of TBK1, ERK1/2, and p38 phosphor-
ylation to those of WT cells (Fig. 6). These results indicate that the
absence of functional SHARPIN decreased NF-kB activation but
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BMDC.
Th2-biased immunogenicity of stimulated cpdm BMDC
The defective IL12 production (Fig. 3A) and Th2-dominant
cytokine profile in cpdm mice [5] suggest that the absence of
SHARPIN affects the ability of cpdm BMDC to induce T cell
differentiation into effector cells. Co-culture of allogeneic naı ¨ve
CD4
+ T cells with WT BMDC stimulated with LPS or poly I:C
elicited robust IFNc production, whereas the concentration of
IFNc in cpdm BMDC-T cell cultures was significantly lower after
LPS stimulation (Fig. 7A), indicating impaired Th1-polarizing
abilities of cpdm BMDC. In addition to TLR3/4 agonists, the
TLR2 ligand Pam3CYS was used since it has been shown to
induce both Th1 and Th2 responses [28–30]. Pam3CYS-matured
WT BMDC induced robust IFNc production at a significantly
higher level than cpdm BMDC (Fig. 7A). The reduced Th1
differentiation following Pam3CYS stimulation is consistent with
the recent report of decreased IL12 production in cpdm
macrophages following TLR2 stimulation [31]. In contrast, more
Figure 1. In vivo and in vitro features of SHARPIN. (A) COILS and MotifScan programs were used to predict the presence of CC (coiled-coil)
domain, UBL (ubiquitin-like) domain and ZFRBP (zinc-finger Ran-Binding protein 2) domain which form similar motif patterns in the SHARPIN protein
of human, mouse and rat origins. (B) Eight week-old females of WT and cpdm mice. The mutant mice (above) develop progressive skin inflammation
starting at about four weeks. (C) Extramedullary hematopoiesis causes marked enlargement of the spleen of cpdm mice. (D) BMDC were incubated in
the absence or presence of 100 ng/ml LPS for 4 hours. The mRNA level of Sharpin was measured by qRT-PCR and presented relative to the mRNA
expression in non-stimulated WT BMDC. Bars represent the mean 6 s.d. of 3 mice. * P,0.05; ** P,0.001. (E) Fibroblast (NIH3T3) and macrophages
(RAW264.7) cells were transfected with the expression plasmid pFLAG-SHARPIN. After 48 hours, cells were fixed and probed with anti-FLAG and FITC-
conjugated secondary antibody. Nuclei were stained with DAPI. In both transfected cell lines, FLAG-SHARPIN was found to be cytoplasm-localized.
doi:10.1371/journal.pone.0031809.g001
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PLoS ONE | www.plosone.org 3 February 2012 | Volume 7 | Issue 2 | e31809Figure 2. Effect of Sharpin mutation on DC subpopulations and maturation. (A) Spleens from WT and cpdm mice were isolated and subject
to collagenase and DNase digestion. The obtained splenic homogenates were centrifuged over a Percoll gradient (35% and 55% density) for
15 minutes. The bands at the 35%-medium and the 35–55% interface were pooled, washed and stained with a combination of various antibodies to
stain different DC subsets, conventional CD11c
+CD8a
+, CD11c
+CD8a
2 and plasmacytoid DC (CD11c
2PDCA-1
+).The top panels were gated on
FSC
hiSSC
lo cells to show separate populations of CD11c
+PDCA-1
2 and CD11c
2PDCA-1
+ cells. Further gating on the CD11c
+PDCA-1
2 subpopulation
gave the bottom panel that showed two distinct pools of CD11c
+CD8a
+ and CD11c
+CD8a
2 cells. Percentages were calculated based on the parental
population and were additionally shown as bar graphs (n=2) (B). (C) WT and cpdm BMDC (5610
5) cells were stimulated with medium, 100 ng/ml LPS
or 25 mg/ml poly I:C for 24 hours. The cells were labeled with PE-labeled anti-CD40, anti-CD80, and anti-CD86, and subjected to flow cytometry
analysis. The populations shown in histograms were gated on CD11c
+ cells. Unstained cells served as negative controls. Results are representative of
two independent experiments.
doi:10.1371/journal.pone.0031809.g002
Role of SHARPIN in Dendritic Cells
PLoS ONE | www.plosone.org 4 February 2012 | Volume 7 | Issue 2 | e31809Figure 3. Defective production of pro-inflammatory mediators from stimulated cpdm BMDC. (A–D) Cultured WT and cpdm BMDC (1610
5
cells in 0.1 ml complete medium) were washed and stimulated with medium, 100 ng/ml LPS or 25 mg/ml poly I:C for 24 hours. Supernatants were
collected for ELISA of IL12P70, IL6, and GMCSF, and for quantification of nitric oxide (NO). (E–F) Gradient numbers (1610
4,2 610
4, and 4610
4 cells in
0.1 mL complete medium) of BMDC were used for100 ng/mL LPS stimulation. After 24 hours, the amounts of IL12P70 and IL6 from the supernatant
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cultures than the WT control (Fig. 7B), suggesting Th2-skewed
immunogenicity of cpdm BMDC. The production of Th17-specific
cytokine IL17A following LPS stimulation of dendritic cells was
similar between stimulated WT and cpdm BMDC cocultures (data
not shown). Despite the distinct Th1- and Th2-stimulating abilities
of WT and cpdm BMDC, they were equally effective in IL2
production from BMDC-T cell co-cultures except for poly I:C
stimulation where WT BMDC induced more IL2 than cpdm
BMDC (Fig. 7C). The Th2-biased stimulating capability of cpdm
BMDC when co-cultured with allogeneic naı ¨ve CD4
+ T cells is
consistent with the Th2-dominant cytokine phenotype observed in
cpdm mice.
Discussion
The present report showed that null mutations of the mouse
Sharpin gene did not affect the steady-state distribution of splenic
DC subsets nor the development and phenotype of BMDC.
However, loss of SHARPIN significantly diminished the capacity
of BMDC to secrete inflammatory cytokines and nitric oxide. The
attenuated cytokine production was not due to the presence of
anti-inflammatory inhibitors, and can be largely explained by
selective inactivation of NF-kB signaling. Stimulated cpdm BMDC
exhibited Th2-biased T cell-polarizing capabilities, consistent with
the Th2 cytokine-dominant phenotype in cpdm mice. Together,
these results indicate an indispensible role of SHARPIN in
regulating DC immunological functions, disruption of which may
contribute to the development of immune diseases.
Since WT and cpdm mice are both specific pathogen-free, the
nature of the trigger of the severe inflammation in cpdm mice is not
obvious. One such initiating factor could be endogenous apoptotic
and/or necrotic cells that can release danger-associated molecular
patterns (DAMPs) to launch and amplify an inflammatory
response [32]. Such ‘sterile’ inflammation could be initiated and
take place in all organs and tissues affected in cpdm mice, thus
causing multi-organ inflammatory disorders. This hypothesis is
supported by several recent studies. Fibroblasts of cpdm mice are
highly sensitive to TNFa-induced cell death and the cpdm
phenotype can be partially rescued by deletion of TNF [7,8],
suggesting that deficiency of SHARPIN compromises the anti-
apoptotic mechanisms in cpdm mice resulting in cell death-induced
inflammatory disease. Apoptosis of keratinocytes is a prominent
feature of the skin lesions in cpdm mice [33] and this is mediated by
caspase-dependent mitochondrial pathways [34]. These induced
and/or intrinsic apoptotic cells can release various types of
DAMPs that exert their pro-inflammatory properties by activating
DC through pattern recognition receptors [32,35], such as
HMGB1 recognized by TLR2/4 [36,37].
Consistent with the impaired Th1 immune response in cpdm
mice [5], stimulated BMDC weakly polarized Th1 differentiation,
but strongly supported the development of Th2 effector cells.
Combined with the dramatic effect of IL12 treatment on the
phenotype of these mice [5], this suggests that the Th2-biased
systemic inflammation in cpdm mice is caused by reduced IL12P70
production from DC. The importance of IL12P70 in regulating
Th1 and Th2 immune responses in mice was clearly demonstrated
in IL12P35- and IL12P40-deficient mice [38,39] and through
clinical studies in human patients [40–42].
NF-kB, TBK/IRF3, and MAPK signaling are important
pathways activated by LPS or poly I:C and disruption of either
pathway may lead to decreased cytokine expression. NF-kB
activation was selectively inhibited in LPS and poly I:C stimulated
cpdm BMDC compared to wild type, while activation of TBK1/
IRF3, ERK1/2, or p38 was not, indicating that disrupted NF-kB
signaling in cpdm DC is responsible for the defective cytokine
expression. These results seem to contradict a recent study that
found increased levels of NF-kB activation and IL1 transcription
in cpdm mice [43]. This difference can probably be attributed to
the different cells and tissues used in these studies, and may point
to cell- and tissue- type specific functions of SHARPIN. This is
consistent with recent reports of tissue-specific effects of NF-kB
signaling [44]. Ubiquitous activation of NF-kB by removing
inhibitors such as A20 and ITCH through genetic manipulation
results in widespread inflammation, consistent with the role of NF-
kB in the production of pro-inflammatory mediators [45,46].
However, selective inhibition of NF-kB activation in parenchymal
cells of the skin, liver, and intestine results in chronic inflammation
driven by NF-kB competent leukocytes [47–50]. This indicates
that a balance between the pro-inflammatory role of NF-kBi n
leukocytes and the anti-inflammatory role in parenchymal cells is
critical in the maintenance of tissue homeostasis. Experiments with
mice with cell- and tissue-specific deletion of Sharpin, currently
under way, will help to elucidate the role of SHARPIN in
inflammation.
Despite defective NF-kB activation in the absence of Sharpin
expression, there was no significant change in splenic DC
populations or expression of co-stimulatory molecules on BMDC.
Different NF-kB subunits involved in the canonical and non-
canonical branches of the NF-kB signaling pathway have distinct
functions to control specific aspects of DC development and
function [51,52]. The non-canonical pathway (p100 processing to
produce p52) appears to be intact in SHARPIN-deficient cells
[7,9] suggesting that the NF-kB heterodimer p52/RELB is
sufficient to maintain the normal regulation of DC homeostasis
and maturation.
The molecular basis by which the Sharpin mutation causes
reduced NF-kB activation in BMDC remains to be determined.
LPS and poly I:C used here are well-defined ligands that
specifically engage TLR4 and TLR3, respectively. The expression
profile of surface TLR4 complexes is similar between WT and
cpdm BMDC suggesting that defective NF-kB activation is not a
result of differential TLR expression on target cells. LPS engages
TLR4 to activate MYD88-dependent and TRIF-dependent
pathways, whereas TLR3 stimulated by poly I:C only triggers
TRIF-dependent signaling [53]. The defective NF-kB activation
by both stimuli suggests that the Sharpin mutation interferes with
the protein adaptors or kinases shared by both signaling pathways,
such as RIP1 and TRAF6 [18]. Recent studies demonstrated that
SHARPIN interacts with HOIP to form LUBAC that exerts its
linear-ubiquitin-chain-ligase activity on NF-kB signaling players
RIP1 and NEMO [7], an essential step for intact TNFa-stimulated
NF-kB activation. The Sharpin null mutation disrupts the
ubiquitylation process and abrogates the TNFa-induced NF-kB
signaling pathway. Since TNFR and TLR partially share their
downstream signaling cascades, a similar ubiquitin-mediated
regulation may hold true for SHARPIN in LPS- and poly I:C-
induced NF-kB activation.
were measured. (G) The cpdm mice rescued by Sharpin-containing BAC had complete remission of the inflammatory phenotype [2]. BMDC developed
from cpdm and rescued cpdm mice were plated (1610
6 cells in 0.3 mL) and stimulated with 100 ng/mL LPS. After 24 hours, supernatants were
collected for analysis of IL12P70 production. Data are representative of three independent experiments. * P,0.01; ** P,0.005.
doi:10.1371/journal.pone.0031809.g003
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PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e31809Figure 4. Decreased mRNA levels of inflammatory cytokines from cpdm BMDC. Cultured WT and cpdm BMDC (5610
5 cells in 0.2 ml
complete medium) were washed and stimulated with 100 ng/ml LPS (A,C,E,G) or 25 mg/ml poly I:C (B,D,F,H). At 0, 1 and 2 hours, total RNA was
extracted and subject to qRT-PCR to measure the expression of Il12p40 (A,B), Il6 (C,D), Gmcsf (E,F), and Ifnb (G,H) mRNA. Bars represent mean 6 SD.
Data are representative of two independent experiments.
doi:10.1371/journal.pone.0031809.g004
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PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e31809In summary, the present study identified an indispensible role of
SHARPIN in the production of pro-inflammatory mediators and
TLR-induced NF-kB signaling. The impaired Th1-stimulating
ability of Sharpin-deficient DC may account for the Th2-dominant
inflammatory phenotype of cpdm mice. The balance between Th1
and Th2 differentiation is critical for immune homeostasis. A
better understanding of how such balance is maintained will help
design cytokine treatment for human diseases with Th2-biased
cytokine secretion similar to the mouse cpdm, such as allergies and
hypereosinophilic syndromes.
Materials and Methods
Ethics Statement
All mouse work was carried out in strict accordance with
protocols approved by the Institutional Animal Care and Use
Committees.
Mice
Specific-pathogen free colonies of C57BL/KaLawRij-Shar-
pin
cpdm/RijSunJ (JR#7599) and WT mice were obtained from
The Jackson Laboratory (Bar Harbor, ME) and were maintained
in a barrier facility. Normal littermate controls were either +/+ or
+/Sharpin
cpdm. These control animals were phenotypically indistin-
guishable and are referred to as WT. Sex-matched WT and
mutant mice were used at 6–10 weeks of age. For some
experiments, cpdm mice were crossed with transgenic mice with a
bacterial artificial chromosome (BAC) containing the Sharpin gene
(FVB/NJ-Tg(RP24-173I23)1Sun/Sun, JR#8279). These mice
were backcrossed onto the C57BL/KaLawRij-Sharpin
cpdm/RijSunJ
background and N4 mice were used in the experiments reported
here. All mouse work was carried out in strict accordance with the
approved protocols by the Institutional Animal Care and Use
Committee.
Constructs and transfection
The complementary DNA (cDNA) of the mouse Sharpin gene was
cloned and amplified from RAW264.7 RNA extracts. The primer
sequenceswereforward, 59-CC ATGGCG ATG TCG CCGCCC
GCC GGC GGT; reverse, 59- AAG CTT CTA GGT GGA AGC
TGC AGC AAG A. The Sharpin cDNA was cloned into expression
vector pFLAG-CMV-2. Murine fibroblasts and macrophages were
were used to express recombinant SHARPIN protein. Cells (2610
4)
were seeded in 96-well treated plates the day before transfection.
After overnight incubation, 200 ng pFLAG-SHARPIN plasmids
were transfected with 0.5 ul Lipofectamine 2000. 24 hours later,
cells were incubated with fresh culture medium. After another
24 hours, cells were lysed to confirm the FLAG-SHARPIN
expression by immunoblots with anti-FLAG. Cells with no
transfection and transfected with empty vector pFLAG-CMV-2
were used as negative control in all transfection experiments.
Generation of BMDC
BMDC were developed as previously reported [54,55]. Cells
were collected after 10–12 days of culture. The cell yield was 2–
3610
7 cells/mouse with 80–95% BMDC.
Figure 5. Normal TLR4 and MD2 expression and decreased IL10 secretion and A20 expression by cpdm BMDC. (A) Unstimulated WT
and cpdm BMDC (5610
5) were labeled with PE-labeled anti-TLR4/MD2 or anti-CD14 and then subject to flow cytometry analysis. Unstained cells serve
as negative controls. (B) Cultured WT and cpdm BMDC (1610
5 cells in 0.1 ml complete medium) were washed and stimulated with medium, 100 ng/
ml LPS or 25 mg/ml poly I:C for 24 hours. Supernatants were collected for ELISA of IL10. (C) Cultured WT and cpdm BMDC (5610
5 cells in 0.2 ml
complete medium) were washed and stimulated with 100 ng/ml LPS or 25 mg/ml poly I:C. At 0, 1, and 2 hours, total RNA was extracted and subject
to qRT-PCR to measure the production of A20.
doi:10.1371/journal.pone.0031809.g005
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The phenotype of BMDC was determined before and after
24 hour culture in the presence of 100 ng/mL LPS. The cells were
incubated in PBS with 0.1% NaN3, 1% BSA and 10% normal
rabbit serum for 20 minutes on ice, washed and incubated for
30 minutes on ice with Alex Fluor-labeled anti-CD11c
Figure 6. Inhibition of NF-kB signaling in cpdm BMDC. WT and cpdm BMDC (2610
6 cells in 0.5 mL complete medium) were stimulated with
100 ng/mL LPS (A) or 25 mg/mL poly I:C (B). At 0, 15, 30, and 60 minutes, whole-cell lysates were obtained and subject to immunoblots with
antibodies against proteins involved in NF-kB, TBK1/IRF3, ERK1/2, and p38 signaling pathways. Beta-actin was used as loading control. (C) Cellular
levels of p-IKK1/2 and p-IkBa in LPS- or poly I:C-stimulated BMDC were quantitated with ImageJ (NIH) and presented as trend lines. Results are
representative of at least two independent experiments.
doi:10.1371/journal.pone.0031809.g006
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23, BD Biosciences), PE-anti-CD80 (16-10A1, eBioscience), PE-
anti-CD86 (P03.1, eBioscience), PE-anti-CD14 (Sa2.8,
eBioscience) and biotinylated anti-TLR4 (BioLegend). The cells
incubated with biotinylated anti-TLR4/MD-2 were washed twice
and incubated for 30 minutes on ice with avidin-PE. To isolate
splenic DC, spleens were collagenase digested and subject to
Percoll gradient centrifugation. The bands at the 35–55%
interface were collected to stain with PE-anti-CD11c (HL3,
BioLegend), APC-anti-PDCA-1 (927, BioLegend) and FITC-
anti-CD8a (53–6.7, BD BioScience). The cells were washed twice,
fixed in 2% paraformaldehyde, and stored at 4uC until analysis.
Flow cytometry was performed in an Excel (Coulter) instrument.
Dead cells were omitted from the analysis by gating on forward
and 90u light scatter, and 10,000 cells were analyzed by FlowJo
software.
BMDC-T cell in vitro interaction
WT and cpdm BMDC (5610
4) were stimulated with medium,
1 mg/mL LPS, 25 mg/mL and 5 mg/mL Pam3CYS. 24 hours
later, cells were collected and washed with PBS. Allogeneic naı ¨ve
CD4
+ T cells were isolated from spleens of BALB/c mice by
negative selection kit (Invitrogen) and were then added at 2.5610
5
and co-cultured with activated BMDC. After 5 days, supernatant
was collected and the secretion of IFNc, IL4, IL2, and IL17A
measured by ELISA. Negative controls are 1) stimulated BMDC
without co-culture with allogeneic CD4
+ T cells; 2) allogeneic
CD4
+ T cells without co-culture with stimulated BMDC. Both
negative controls show no production of aforementioned cyto-
kines.
RNA expression by BMDC
BMDC were cultured at 10
6 cells/mL in 10 mL of RPMI-1640
complete medium in the presence or absence of 100 ng/mL LPS
or 25 mg/mL poly I:C. After 1 and 2 hours, RNA was isolated
with TRI-reagent (Sigma) according to the manufacturer’s
instructions. The expression of Il6, Il12p40, Gmcsf, and Sharpin
mRNA was determined by qRT-PCR. Primers and probes were
purchased from Applied Biosystems. Reverse transcription was
performed at 42uC for 60 minutes with the final denaturation step
at 90uC for 5 minutes in 30 ml containing 0.5 mg of total RNA.
dNTPs, oligo(dT)15 primer, recombinant RNasin Ribonuclease
Inhibitor, and M-MLV Reverse Transcriptase (all from Promega,
Madison, WI) were used according to the manufacturer’s
instruction. Reverse transcription was done in a PTC-200 Peltier
Thermal Cycler (MJ Research, Watertown, MA). qRT-PCR was
Figure 7. Stimulated cpdm BMDC induced Th2-biased cytokine production from naı ¨ve CD4
+ T cells. WT and cpdm BMDC (5610
4 cells in
0.1 mL complete medium; MHC haplotype: H-2
b) were incubated with medium, 100 ng/mL LPS, 25 mg/mL poly I:C or 5 mg/mL Pam3CYS. After
24 hours, cells were washed with PBS and incubated with freshly isolated allogeneic naı ¨ve CD4
+ T cells (2.5610
5 cells in 0.1 mL complete medium;
MHC haplotype: H-2
d). After 5 days, supernatants were collected and the secretion of IFNc, IL4, and IL2 were measured by ELISA. Negative controls
are 1) stimulated BMDC without co-culture with allogeneic CD4
+ T cells; 2) allogeneic CD4
+ T cells without co-culture with stimulated BMDC. Samples
from both negative controls had no detectable production of the aforementioned cytokines (not shown). Results are analyzed based on 2–4 mice per
group. * P,0.05.
doi:10.1371/journal.pone.0031809.g007
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TaqManH Gene Expression Assays (Applied Biosystems, Foster
City, CA) for mouse Actb, IL6, IL12p40, Ifnb, Gmcsf, and Sharpin
according to the manufacturer’s protocol. The endogenous
standard for normalization of the target gene was b-actin. Relative
gene expression was calculated using the 2
2DDCt method [56].
In vitro cytokine secretion by BMDC
The BMDC were cultured in triplicate wells of 24-well or 96-
well plates at 10
6 or 10
5 cells/mL, respectively, in RPMI-1640
complete medium. The cells were washed and stimulated with
100 ng/mL LPS or 25 mg/mL poly I:C. After 24 hours,
supernatants were harvested for ELISA analysis. The presence
of nitrite in the supernatants was determined using the Griess
reagent.
Immunofluorescence
Fibroblast and macrophage cells were transfected with pFLAG-
SHARPIN. 48 hours later, cells were washed briefly with PBS,
then fixed in cold methanol at 220uC for 10 minutes and cold
acetone at -20uC for 1 minute. Incubate cells with PBS+1% BSA
for 15 minutes to block non-specific binding. Fixed cells were then
incubated with anti-FLAG (1:100) as the primary antibody at
room temperature for 1 hour, followed by three 5-minute washes.
Cells were further incubated with goat anti-rabbit IgG-FITC
(1:100) as the secondary antibody at room temperature for
30 minutes, followed by three 5-minute washes. Cells were then
examined using inverse fluorescence microscope.
Immunoblots
After adding stimulating ligands, 100 ng/mL LPS or 25 mg/mL
poly I:C, BMDC were collected and lysed at 0-, 15-, 30-, and 60-
minute time points. Immunoblots were performed with antibodies
(Cell Signaling Technology) against p-IKK1/2(#2697), p-IkBa
(#9246), IkBa (#4814), p-TBK1(#5483), p-p38 (#9216), p38
(#9212), p-ERK1/2 (#4376), and ERK1/2 (#4695). Beta-actin
(sc-47778, Santa Cruz Biotechnology) was used as loading control.
Statistical analysis
Data are expressed as mean 6 SD. The statistical significance of
differences of means between experimental groups was determined
by Students’ t-test.
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